Confirmation of the first case of Ebola in the United States lifted
shares of Tekmira Pharmaceuticals Corp. (Nasdaq: TKMR) $5.75 to $26.89, whose potential
treatment of the rare disease was authorized for emergency use by the
Food and Drug Administration.
Tekmira soars on first confirmed domestic Ebola case
October 01, 2014 at 14:57 PM EDT